Aharona Glatman‐Freedman

Author

Also Known As

A Glatman-Freedman, A. Glatman-Freedman, Aharona Glatman-Freedman, Aharona Glatman-freedman, Aharona Glatman‐Freedman, Dan Riesel, David Richardso, T. Shohat, Tomer Hertz

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Israel Ministry of Health Tel Aviv University Albert Einstein College of Medicine Sheba Medical Center New York Medical College

About

Aharona Glatman‐Freedman is an author at Israel Ministry of Health specializing in medicine, epidemiology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	23	1.1K
2	Public Health	10	10	3.2K
3	Engineering	1	1	24
4	Natural Sciences	1	1	37
5	Allergy	1	1	24

Aharona Glatman‐Freedman

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study A. Danielle Iuliano, Katherine Roguski, Howard H. Chang, The Lancet Infectious Disease ModellingGlobal HealthEpidemiological DynamicModelling StudyComputational Epidemiology	2017	2.9K
Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice Rafael Prados‐Rosales, Andrés Baena, Luis R. Martinez, Journal of Clinical Investigation Microbial PathogensInnate Immune SystemImmunologyInnate ImmunityBacterial Pathogens	2011	360
Characterization of a Murine Monoclonal Antibody to<i>Cryptococcus neoformans</i>Polysaccharide That Is a Candidate for Human Therapeutic Studies Arturo Casadevall, Wendy Cleare, Marta Feldmesser, Antimicrobial Agents and Chemotherapy	1998	303
A mAb recognizing a surface antigen of<i>Mycobacterium tuberculosis</i>enhances host survival Rachel Teitelbaum, Aharona Glatman‐Freedman, Bing Chen, Proceedings of the National Academy of Sciences	1998	274
Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021 Moran Weinberger Opek, Yonatan Yeshayahu, Aharona Glatman‐Freedman, Eurosurveillance Respiratory Virus ImmunityVirus EpidemiologyRespiratory ComplicationsDisease OutbreakCovid-19	2021	143
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction Tingting Chen, Caroline Blanc, Anke Z. Eder, The Journal of Infectious Diseases	2016	137
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine Rafael Prados‐Rosales, Leandro J. Carreño, Tingting Cheng, PLoS Pathogens Microbial PathogensImmunologyImmunotherapyInfection ControlPa-am Conjugates	2017	87
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021 Aharona Glatman‐Freedman, Yael Hershkovitz, Zalman Kaufman, Emerging infectious diseases VaccinologyVaccine SafetyVaccinationBnt162b2 VaccineVaccine Development	2021	75
Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria Aharona Glatman‐Freedman, Jean Martin, Paul Riska, Journal of Clinical Microbiology Immunocytochemical TechniqueImmunologyImmunodominanceImmunotherapyMycobacterium Tuberculosis	1996	65
Glucan Is a Component of the<i>Mycobacterium tuberculosis</i>Surface That Is Expressed In Vitro and In Vivo J. Reid Schwebach, Aharona Glatman‐Freedman, Leslie Gunther-Cummins, Infection and Immunity	2002	63

Page 1